X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (12) 12
humans (12) 12
middle aged (9) 9
adult (8) 8
index medicus (8) 8
oncology (7) 7
aged (6) 6
breast neoplasms - drug therapy (6) 6
immunology (6) 6
quinazolines - administration & dosage (6) 6
breast neoplasms - pathology (5) 5
infectious diseases (5) 5
lapatinib (5) 5
trastuzumab (5) 5
treatment outcome (5) 5
animals (4) 4
breast cancer (4) 4
breast neoplasms - metabolism (4) 4
disease-free survival (4) 4
drug administration schedule (4) 4
drug resistance, viral (4) 4
efficacy (4) 4
male (4) 4
skin and connective tissue diseases (4) 4
virology (4) 4
aged, 80 and over (3) 3
algorithms (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols (3) 3
biomarkers, tumor - analysis (3) 3
breast neoplasms (3) 3
breast neoplasms - mortality (3) 3
cattle (3) 3
combination (3) 3
estrogen-receptor (3) 3
expression (3) 3
her2 (3) 3
hiv-1 - drug effects (3) 3
hiv-1 - genetics (3) 3
immunohistochemistry (3) 3
kaplan-meier estimate (3) 3
nitriles - administration & dosage (3) 3
paclitaxel (3) 3
postmenopause (3) 3
receptor, erbb-2 - genetics (3) 3
triazoles - administration & dosage (3) 3
academia–pharma intersect (2) 2
amplification (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
aromatase inhibitors (2) 2
breast neoplasms - genetics (2) 2
comparative analysis (2) 2
diagnosis (2) 2
dosage and administration (2) 2
double-blind method (2) 2
drug therapy (2) 2
erbb-2 (2) 2
genotype (2) 2
hiv infection (2) 2
hiv infections - drug therapy (2) 2
hiv protease inhibitors - pharmacology (2) 2
hiv-1-infected patients (2) 2
human-immunodeficiency-virus (2) 2
inhibitor (2) 2
letrozole (2) 2
lymph nodes - microbiology (2) 2
microbial sensitivity tests - methods (2) 2
mutations (2) 2
neoplasm staging (2) 2
nitriles - adverse effects (2) 2
paclitaxel - administration & dosage (2) 2
patterns (2) 2
phenotype (2) 2
plus (2) 2
prognosis (2) 2
proportional hazards models (2) 2
protease (2) 2
quinazolines - adverse effects (2) 2
receptor, erbb-2 (2) 2
receptor, erbb-2 - antagonists & inhibitors (2) 2
receptor, erbb-2 - metabolism (2) 2
receptors, estrogen - biosynthesis (2) 2
receptors, estrogen - genetics (2) 2
receptors, progesterone - biosynthesis (2) 2
receptors, progesterone - genetics (2) 2
recommendations (2) 2
research (2) 2
research article (2) 2
respiratory system (2) 2
responses (2) 2
retrospective studies (2) 2
safety (2) 2
society-usa panel (2) 2
tamoxifen resistance (2) 2
targeted therapy (2) 2
therapy (2) 2
triazoles - adverse effects (2) 2
vaccination - veterinary (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5538 - 5546
Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial... 
EFFICACY | ONCOLOGY | RANDOMIZED PHASE-II | TAMOXIFEN RESISTANCE | GROWTH | MCF-7 CELLS | COMBINATION | INHIBITOR | EXPRESSION | ESTROGEN-RECEPTOR | PLUS | Triazoles - administration & dosage | Triazoles - adverse effects | Postmenopause - drug effects | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Carcinoma - secondary | Carcinoma - drug therapy | Receptors, Estrogen - genetics | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Breast Neoplasms - pathology | Quinazolines - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasm Staging | Nitriles - adverse effects | Index Medicus | Carcinoma | Quinazolines | Breast Neoplasms | Life Sciences | Immunology | Triazoles | Postmenopause | Nitriles | Antineoplastic Agents, Hormonal | Tumor Markers, Biological | Receptors, Estrogen | Neoplasm Invasiveness | Antineoplastic Combined Chemotherapy Protocols | Receptor, erbB-2 | Receptors, Progesterone | Kaplan-Meiers Estimate
Journal Article
The Oncologist, ISSN 1083-7159, 02/2010, Volume 15, Issue 2, pp. 122 - 129
Journal Article
The Oncologist, ISSN 1083-7159, 06/2013, Volume 18, Issue 6, pp. 661 - 666
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 1999, Volume 159, Issue 2, pp. 439 - 446
Journal Article
BMC Research Notes, ISSN 1756-0500, 12/2013, Volume 6, Issue 1, pp. 507 - 507
To define protein molecular characteristics of tumor cells prior to, and immediately following, preoperative human epidermal growth factor receptor 2... 
Invasive breast cancer | Protein signaling | Lapatinib | Autophagy | Trastuzumab | Carcinoma, Ductal, Breast - genetics | Phosphorylation | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Biomarkers, Pharmacological | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Breast Neoplasms - metabolism | STAT5 Transcription Factor - genetics | STAT5 Transcription Factor - metabolism | Carcinoma, Ductal, Breast - drug therapy | Antibodies, Monoclonal, Humanized - administration & dosage | Forkhead Transcription Factors - metabolism | Adult | Carcinoma, Ductal, Breast - pathology | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Paclitaxel - administration & dosage | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Drug Administration Schedule | Antineoplastic Combined Chemotherapy Protocols | PTEN Phosphohydrolase - metabolism | Forkhead Transcription Factors - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Aged | Forkhead Box Protein O1 | Medicine, Experimental | Medical research | Epidermal growth factor | Tumors | Statistical analysis | Oncology | Breast cancer | Cancer therapies | Proteins | Confidence intervals | Chemotherapy | Surgery | Proteomics | Response rates | Biomarkers | Deoxyribonucleic acid--DNA
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 12/2005, Volume 40, Issue 4, pp. 422 - 427
Journal Article
The Oncologist, ISSN 1083-7159, 03/2010, Volume 15, Issue 3, pp. 327 - 327
Journal Article
AIDS Research and Therapy, ISSN 1742-6405, 04/2009, Volume 6, Issue 1, pp. 3 - 3
Traditional first line regimens containing a non-nucleoside reverse transcriptase inhibitor or protease inhibitor may not be suitable for a subset of... 
Antiviral agents | Dosage and administration | Diagnosis | Research | Comparative analysis | Drug therapy | HIV infection
Journal Article
Savannah Morning News, ISSN 1047-028X, 02/2007
St. Joseph's/Candler will be performing mammograms to screen for breast cancer in its mobile screening unit Feb. 6 and 20 at St. Joseph's/Candler Medical Group... 
Newspaper Article